Accéder au contenu
Merck

Looking for new pyrimidine acyclic nucleotide analogues designed for phosphorylation by human UMP-CMP kinase.

Nucleosides, nucleotides & nucleic acids (2007-12-11)
Dimitri Topalis, Hiroki Kumamoto, Julie A C Alexandre, Laurence Dugué, Sylvie Pochet, Sabine Berteina-Raboin, Luigi A Agrofoglio, Dominique Deville-Bonne
RÉSUMÉ

Human UMP-CMP kinase is involved in the phosphorylation of nucleic acid precursors and also in the activation of antiviral analogues including cidofovir, an acyclic phosphonate compound that mimicks dCMP and shows a broad antiviral spectrum. The binding of ligands to the enzyme was here investigated using a fluorescent probe and a competitive titration assay. At the acceptor site, the enzyme was found to accommodate any base, purine and pyrimidine, including thymidine. A method for screening analogues based on their affinity for the UMP binding site was developed. The affinities of uracil vinylphosphonate derivatives modified in the 5 position were found similar to (d)UMP and (d)CMP and improved when compared to cidofovir.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Vinylphosphonic acid, 97%
Sigma-Aldrich
Cytidine 5′-diphosphate sodium salt hydrate, from yeast, ≥95%
Sigma-Aldrich
Vinylphosphonic acid, ≥90% (T)
Sigma-Aldrich
2′-Deoxycytidine 5′-diphosphate sodium salt, ≥96%